Closo-Carboranyl- and Metallacarboranyl [1,2,3]triazolyl-Decorated Lapatinib-Scaffold for Cancer Therapy Combining Tyrosine Kinase Inhibition and Boron Neutron Capture Therapy

One of the driving forces of carcinogenesis in humans is the aberrant activation of receptors; consequently, one of the most promising mechanisms for cancer treatment is receptor inhibition by chemotherapy. Although a variety of cancers are initially susceptible to chemotherapy, they eventually deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Couto, Marcos, Alamón, Catalina, García, María Fernanda, Kovacs, Mariángeles, Trias, Emiliano, Nievas, Susana, Pozzi, Emiliano, Curotto, Paula, Thorp, Silvia, Dagrosa, María Alejandra, Teixidor, Francesc, Viñas, Clara, Cerecetto, Hugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349914/
https://www.ncbi.nlm.nih.gov/pubmed/32517054
http://dx.doi.org/10.3390/cells9061408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349914/
https://www.ncbi.nlm.nih.gov/pubmed/32517054
http://dx.doi.org/10.3390/cells9061408

Ejemplares similares